These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6439851)
1. Absorption of gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide citrate (DN-1417), an analog of thyrotropin-releasing hormone, in rats and dogs. Yokohama S; Yoshioka T; Kitamori N J Pharmacobiodyn; 1984 Aug; 7(8):527-35. PubMed ID: 6439851 [TBL] [Abstract][Full Text] [Related]
2. Absorption of thyrotropin-releasing hormone after oral administration of TRH tartrate monohydrate in the rat, dog and human. Yokohama S; Yamashita K; Toguchi H; Takeuchi J; Kitamori N J Pharmacobiodyn; 1984 Feb; 7(2):101-11. PubMed ID: 6427443 [TBL] [Abstract][Full Text] [Related]
4. Radioimmunoassay for an analog of thyrotrophin-releasing hormone, gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide (DN-1417). Shiota K; Miyake A; Tsunoda C; Oka Y; Nagawa Y; Nakayama R J Immunol Methods; 1982; 51(1):69-80. PubMed ID: 6809831 [TBL] [Abstract][Full Text] [Related]
5. [A TRH analog (DN-1417). Blood level and brain distribution determined by radioimmunoassay after intravenous administration in rats]. Nagai Y; Narumi S; Saji Y; Nagawa Y Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):231-42. PubMed ID: 3924797 [TBL] [Abstract][Full Text] [Related]
6. Kinetic study on disappearance of gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide (DN-1417) from plasma using a radioimmunoassay for DN-1417 isobutylamide. Oshima I; Saito S; Shiota K; Miyake A; Oka Y; Nakayama R J Pharmacobiodyn; 1983 Mar; 6(3):202-8. PubMed ID: 6410041 [TBL] [Abstract][Full Text] [Related]
7. Increase in rat regional brain cyclic nucleotides by thyrotropin-releasing hormone (TRH) and its analog DN-1417. Narumi S; Nagai Y; Saji Y; Nagawa Y Jpn J Pharmacol; 1983 Oct; 33(5):915-26. PubMed ID: 6139495 [TBL] [Abstract][Full Text] [Related]
8. Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analogues. Ogawa N; Mizuno S; Mori A; Nukina I; Ota Z; Yamamoto M Peptides; 1984; 5(4):743-6. PubMed ID: 6436797 [TBL] [Abstract][Full Text] [Related]
9. Intracerebroventricular injection of a TRH analogue, gamma-butyrolactone-gamma-carbonyl-L-histidyl-prolinamide, induces gastric lesions and gastric acid stimulation in rats. Maeda-Hagiwara M; Watanabe H Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):142-6. PubMed ID: 3930976 [TBL] [Abstract][Full Text] [Related]
10. A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats. Narumi S; Nagai Y; Saji Y; Nagawa Y Jpn J Pharmacol; 1985 Dec; 39(4):425-35. PubMed ID: 2869169 [TBL] [Abstract][Full Text] [Related]
11. Effects of thyrotropin releasing hormone and its analogue, DN 1417, on biopterin concentration and tryptophan hydroxylation in rat raphe slices. Sawada M; Hirata Y; Minami M; Nagatsu T Life Sci; 1987 Dec; 41(25):2733-7. PubMed ID: 3121968 [TBL] [Abstract][Full Text] [Related]
12. Antiepileptic effects of thyrotropin-releasing hormone and its new derivative, DN-1417, examined in feline amygdaloid kindling preparation. Sato M; Morimoto K; Wada JA Epilepsia; 1984 Oct; 25(5):537-44. PubMed ID: 6434294 [TBL] [Abstract][Full Text] [Related]
13. In vitro thyrotrophin release with thyrotropin-releasing hormone and an analogue, DN-1417. Shiota K; Yoshida K; Noguchi C; Nakayama R Acta Endocrinol (Copenh); 1984 May; 106(1):71-8. PubMed ID: 6428117 [TBL] [Abstract][Full Text] [Related]
14. [A TRH analog (DN-1417). Effects on the levels of monoamines and the metabolites in the various brain regions in rats]. Nagai Y; Narumi S; Miyamoto M; Shima T; Saji Y; Nagawa Y Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):209-20. PubMed ID: 3924795 [TBL] [Abstract][Full Text] [Related]
15. Effects of thyrotropin releasing hormone and its analogues on unconsciousness following head injury in mice. Tanaka K; Ogawa N; Chou H; Mori A; Yanaihara N Regul Pept; 1992 Mar; 38(2):129-33. PubMed ID: 1574607 [TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant effect of DN-1417, a derivative of thyrotropin-releasing hormone, and liposome-entrapped DN-1417, on amygdaloid-kindled rats. Mori N; Fukatsu T Epilepsia; 1992; 33(6):994-1000. PubMed ID: 1464282 [TBL] [Abstract][Full Text] [Related]
17. A TRH analog (DN-1417): effects on local cerebral glucose utilization in conscious and pentobarbitalized rats determined by the autoradiographic 2-deoxy-[14C]glucose method. Nagai Y; Narumi S; Miyamoto M; Saji Y; Nagawa Y Jpn J Pharmacol; 1983 Jun; 33(3):635-45. PubMed ID: 6413736 [TBL] [Abstract][Full Text] [Related]
18. TRH and its novel analog (DN-1417): antipentobarbital action and involvement of cholinergic mechanisms. Miyamoto M; Nagai Y; Narumi S; Saji Y; Nagawa Y Pharmacol Biochem Behav; 1982 Oct; 17(4):797-806. PubMed ID: 6817348 [TBL] [Abstract][Full Text] [Related]
19. Gamma-butyrolactone-gamma-carbonyl-histidyl-prolinamide citrate (DN-1417): a novel TRH analog with potent effects on the central nervous system. Miyamoto M; Fukuda N; Narumi S; Nagai Y; Saji Y; Nagawa Y Life Sci; 1981 Feb; 28(8):861-9. PubMed ID: 6783804 [No Abstract] [Full Text] [Related]
20. Thyrotropin-releasing hormone (TRH) and its analog (DN-1417): interaction with pentobarbital in oxygen consumption and cyclic AMP formation of rat cerebral cortex slices. Narumi S; Nagai Y; Saji Y; Nagawa Y Life Sci; 1984 May; 34(22):2177-84. PubMed ID: 6328158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]